https://www.selleckchem.com/pr....oducts/phosphoramido
The treatment of breast cancer has progressed considerably over the years, with a significant de-escalation from radical mastectomies to the current paradigm of breast conserving surgery (BCS) and neoadjuvant chemotherapy (NACT). We aimed to appraise the literature regarding the feasibility of de-escalation of treatment of axillary disease in the context of NACT. We appraised studies and guidelines published regarding this topic and discussed them in this mini-review. The SNB following NACT is oncologically safe in
Like
Comment
Share
